The Waters Corporation (WAT) provides analytical workflow solutions globally. It has a strong market presence in the healthcare sector, specializing in diagnostics and research. The stock is currently under analyst focus due to its innovative product solutions in high-performance instrumentation.
Waters Corporation has been assigned a fundamental rating of B+. The scores offer insight into the company's valuation metrics, including discounted cash flow, return on equity, and debt to equity ratio.
Category | Score | Visual |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 5 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 2 | |
Price to Book | 1 |
A comparison of historical ratings offers insights into the company's consistent performance over time.
Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-07-03 | 3 | 4 | 5 | 5 | 1 | 2 | 1 |
NA | 0 | 4 | 5 | 5 | 1 | 2 | 1 |
The analyst price targets provide insights into the expected market performance of the stock.
High | Low | Median | Consensus |
---|---|---|---|
400 | 374 | 387 | 387 |
Analyzing analyst recommendations provides a look into market sentiment towards the stock.
Recommendation | Count | Visual |
---|---|---|
Strong Buy | 0 | |
Buy | 10 | |
Hold | 19 | |
Sell | 3 | |
Strong Sell | 0 |
Waters Corporation has a strong position in the healthcare diagnostics and research sector, with solid fundamental ratings and consistent scores over time. Analyst sentiment suggests a 'Hold' consensus due to balanced buy and hold positions. Challenges include a moderate debt-to-equity ratio. Investors should consider these factors alongside the industry's growth potential.